Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

NCT06650462 | Completed

• 1 other identifier: 22-10-FB-0215 - Study 1
• Study Type: interventional
• Target: 57
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Conditions

COVID-19; Trust

Keywords

community-led; COVID-19; trust; vaccine hesitancy; peer mentor; community advisory board

Outcome Measures

Primary Outcomes (4)

• Openness to COVID-19 testing

  The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.

  0 months, 3 months, 6 months

• COVID-19 Testing Efficacy

  The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.

  0 months, 3 months, 6 months

• COVID-19 Trust

  Two items assessing (1) trust in the safety of the COVID-19 vaccine, and (2) trust in the efficacy of the COVID-19 vaccine were used to assess participants' trust relating to COVID-19. Each item is rated on a 5-point Likert scale. Higher scores indicate greater trust.

  0 months, 3 months, 6 months

• Qualitative feedback

  Qualitative feedback will be obtained from participants in a group feedback session

  4 months

Secondary Outcomes (1)

• COVID-19 Vaccine Hesitancy

  0 months, 3 months, 6 months

Study Arms (2)

Control

NO INTERVENTION

non-intervention control (participants complete surveys only)

Intervention

EXPERIMENTAL

Participants engage in weekly community-led small group discussions about health-related topics and answer surveys at 0, 3, and 6 months time points

Behavioral: Community-led discussion

Interventions

Community-led discussion BEHAVIORAL

Participants engage in weekly community-led small group discussions about health related topics

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older
• Resident of one of the 9 housing authority agencies
• Willing to participate in Zoom meetings and complete online assessments at baseline, 3-month, and 6-month timepoints
• Ability to read, speak, and understand English

You may not qualify if:

• None

Sponsors & Collaborators

• Old Dominion University: lead

Study Sites (1)

Macon & Joan Brock Virginia Health Institute at Old Dominion University

Norfolk, Virginia, 23507, United States

Location

MeSH Terms

Conditions

COVID-19; Vaccination Hesitancy

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Vaccination Refusal; Treatment Refusal; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Kelli J England, PhD

  Old Dominion University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Model Details: Participants randomly assigned to intervention or control group; repeated measure assessments at 0 months, 3 months, 6 months

Study Record Dates

• First Submitted: October 16, 2024
• First Posted: October 21, 2024
• Study Start: July 2, 2024
• Primary Completion: April 1, 2025
• Study Completion: April 1, 2025
• Last Updated: February 27, 2026

Record last verified: 2026-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)